Current concepts of cutaneous porphyria and its treatment with particular reference to the use of sodium calciumedetate.
D001315:Australia; D001463:Barbiturates / Q000009:adverse effects; D002738:Chloroquine / Q000627:therapeutic use; D002792:Cholestyramine Resin / Q000627:therapeutic use; D004035:Diet Therapy; D004492:Edetic Acid / Q000627:therapeutic use*; D004967:Estrogens / Q000009:adverse effects; D006118:Griseofulvin / Q000009:adverse effects; D006801:Humans; D011164:Porphyrias / Q000188:drug therapy* / Q000453:epidemiology / Q000378:metabolism; D013449:Sulfonamides / Q000009:adverse effects; D013471:Sunburn
D001463:Barbiturates; D004967:Estrogens; D013449:Sulfonamides; D002792:Cholestyramine Resin; D006118:Griseofulvin; D002738:Chloroquine; D004492:Edetic Acid